32 HPV Genotypes32 named target entries · 1 included assay · 32 HPV Genotypes
Samples
Swab + LBCPreparation tailored to the sample
Results
24 hoursListed laboratory turnaround
Collection
IncludedArrange with the care team
THE PURPOSE BEHIND THE PANEL.
Choose the scope. Understand the result.
A molecular panel reporting the thirty-two listed HPV genotypes from an appropriate swab or liquid-based cytology specimen.
2named targets
2 listed entries
Two individually named genotypes
This view contains 2 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
What this means in context
An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
30named targets
30 listed entries
The remaining named assay targets
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
What this means in context
An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
1laboratory assay
1 included assay
The panels behind the named targets.
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase.
What this means in context
An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
KNOW EXACTLY WHAT YOU ARE CHOOSING.
32 HPV Genotypes. The scope, made clear.
The assay lists 32 HPV genotypes. The inventory shows the genotype names without translating the laboratory’s broad risk labels into a clinical classification. Interpretation and follow-up use the applicable screening pathway and the individual result.
32HPV Genotypes
32named target entries1 included assay
Swab + LBCListed specimen types
32 named target entries · 1 included assay · 32 HPV Genotypes
HPV 16 & 18
2 entries
HPV 16
This view contains 2 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 18
This view contains 2 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Other reported genotypes
30 entries
HPV 6
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 11
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 32
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 34
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 40
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 42
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 43
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 44
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 54
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 61
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 72
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 81
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 26
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 31
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 33
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 35
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 39
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 45
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 51
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 52
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 53
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 56
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 58
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 59
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 66
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 68
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 69
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 70
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 73
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
HPV 82
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Included laboratory assays
1 entry
HPV PCR
Looks for the listed HPV genotypes in an appropriate specimen. Detection of HPV is not a diagnosis of cancer.
Try a test or target name, or choose another health focus.
Checking a prescription? Let’s make sure it matches.
THE RIGHT START DEPENDS ON YOU.
A useful package. A personal decision.
Choose the investigation around the question you want to discuss. An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
01
A defined question
A molecular panel reporting the thirty-two listed HPV genotypes from an appropriate swab or liquid-based cytology specimen.
02
Matching a prescription
Compare the full included list with your clinician’s request. An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
03
Following a previous finding
Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.
MAKE THE SAMPLE COUNT.
A little preparation. A more useful result.
Preparation follows the actual specimen and tests in HPV 32. Confirm your personal instructions before collection.
02
Swab + LBC.One coordinated pathway.
YOUR PREPARATION0 of 4 ready
A personal checklist. Your care team confirms the instructions.
YOUR COLLECTION. YOUR CHOICE.
Care comes to you. Or visit your laboratory.
Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.
YOUR PLACE. THE SAME LABORATORY PATHWAY.
A familiar setting. A professional collection.
Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.
Collection fee included for this package’s visit
Choose the person and location in the shared checkout
Need another time? Request the earliest available appointment
Across Dubai
THE LABORATORY. READY TO WELCOME YOU.
Your visit. In Deira.
Intel Lab · Deira 101–102, Al Hawai Building, Al Rigga Road, Al Muraqqabat, Deira, Dubai
Follow HPV 32 from your care bag to an informed conversation.
The right package. The right person.
Choose & assign
Add HPV 32 to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.
Preparation follows the test.
Prepare & collect
Confirm the instructions for swab + lbc and the appropriate collection arrangements. Correct identification, specimen choice and timing support a useful result.
Laboratory work, behind the finding.
Analyse & report
Intel Lab processes the sample and checks the report. The package lists 24 hours; collection timing and any additional laboratory checks may affect release.
A finding, placed in your context.
Understand & follow up
Read the report with the reason for testing. A clinician can explain unexpected findings, relevant limitations and whether any further assessment is appropriate.
MORE THAN A LIST OF NUMBERS.
Read the result. Understand the context.
Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
Laboratory informationClinical interpretation
RESULT + CONTEXT
Two individually named genotypes
This view contains 2 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
Questions to take to your clinician
What does this part of my result add to the clinical question?
Does the sample timing or a medicine affect this finding?
What follow-up is appropriate for this specific result?
UNDERSTANDING YOUR REPORT
Swab / LBC
Other reported genotypes
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
Laboratory informationClinical interpretation
RESULT + CONTEXT
The remaining named assay targets
This view contains 30 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
Questions to take to your clinician
What does this part of my result add to the clinical question?
Does the sample timing or a medicine affect this finding?
What follow-up is appropriate for this specific result?
UNDERSTANDING YOUR REPORT
Swab / LBC
Included laboratory assays
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
Laboratory informationClinical interpretation
RESULT + CONTEXT
The panels behind the named targets.
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase. An HPV result is not a diagnosis of cervical cancer, and HPV testing is not the same as cytology. The appropriate screening pathway depends on age and clinical history.
Questions to take to your clinician
What does this part of my result add to the clinical question?
Does the sample timing or a medicine affect this finding?
What follow-up is appropriate for this specific result?
THE NEXT STEP IS PERSONAL.
Bring the findings back to you.
Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.
01
Follow the appropriate screening pathway
Discuss the reported genotype result with previous screening findings and clinical history. HPV detection is not a cancer diagnosis; the appropriate follow-up depends on the result and the relevant screening guidance.
02
Agree the next step
Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.
Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.
1M+biomarkers reported annually
25+years in medicine · Dr Nirupama
Identify and protect the sample
Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.
Analyse with quality controls
The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.
Review before the report is released
Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.
Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.
Clinical author
Dr Nirupama Sabhapathy
Laboratory Director · Intel Lab
Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.
Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.
Choosing for a particular need? We can help you read the options.
BEFORE YOU BOOK.
A little more clarity.
Preparation, sample types, timing and what the package does—and does not—include.
What is included in HPV 32?
Know the HPV genotype scope. The full named inventory on this page is the scope of the package.
Does a positive HPV result mean cancer?
No. HPV detection identifies infection with a listed genotype. Follow-up depends on the genotype, previous results and the relevant clinical screening pathway.
Is HPV testing the same as a cervical smear?
No. HPV testing looks for viral genetic material; cytology assesses cell changes. They can play different roles within a screening pathway.
Can a positive HPV result establish when infection was acquired?
No. The result cannot reliably date acquisition or identify a particular partner.
Does a negative result cover every HPV type?
No. It describes the genotypes included in this assay and the submitted specimen at that time.
How should I prepare?
Ask whether menstrual bleeding, vaginal products, recent intercourse or treatment affect the planned collection, and follow the instructions for this assay.
Can I arrange collection in Dubai?
Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.
What is the price and expected turnaround?
The package price is AED 999; the listed turnaround is 24 hours. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.
What happens after I receive the result?
Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.
YOUR NEXT STEP. AROUND YOU.
A clearer question. A more informed next step.
HPV 32 · 32 HPV Genotypes · Swab + LBC
AED999collection included for this package’s visit